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Introduction: Deep vein thrombosis is a common com-
plaint in patients which can be caused by factors such as 
surgery. Medical and mechanical methods such as stoc-
kings are used to prevent this complication. Although se-
veral studies have examined and compared the effects of 
these methods, is no study has compared these methods 
in hysterectomy. The purpose of the current research was 
to compare the use of heparin and enoxaparin alone and 
along with compression stockings in terms of incidence of 
deep vein thrombosis.
Methodology: To do the research, 80 patients were ran-
domly assigned into 4 groups of heparin alone, heparin 
along with stockings, enoxaparin alone, and enoxaparin 
along with stockings (each contained 20 patients). In the 
first group, heparin at the dose of 5000 units per 12 hours 
for 3 days was used subcutaneously. In the second group, 
in addition to heparin, compression stockings were also 
utilized. In the third group underwent prophylaxis, enoxa-
parin at the dose of 40 mg per day for three days was 
used subcutaneously. In the fourth group, in addition to 
enoxaparin, compression stockings were also used. Two 
weeks after the completion of the medical and mechanical 
prophylaxis, thrombosis was examined through Doppler 
ultrasonography. Data were analyzed using SPSS, version 
22, software and chi-square test (Fisher test) and ANOVA.
Results: Only two cases of thrombosis (one case in the 
first group and one case in the third group) were obser-
ved. No case of thrombosis was seen in groups receiving 
compression stockings along with medicine. Fisher’s exact 
test indicated that there was no significant difference 
among four groups in terms of incidence of thrombosis.
Conclusion: Adding compression stockings to heparin or 
enoxaparin had no significant effect on reducing the inciden-
ce of deep vein thrombosis in patients with hysterectomy.
Keywords: heparin, enoxaparin, stockings, deep vein 
thrombosis, hysterectomy.
Introducción: la trombosis venosa profunda es una queja 
común en pacientes que puede ser causada por factores 
como la cirugía. Los métodos médicos y mecánicos, como 
las medias, se utilizan para prevenir esta complicación. 
Aunque varios estudios han examinado y comparado los 
efectos de estos métodos, ningún estudio ha compara-
do estos métodos en la histerectomía. El propósito de la 
investigación actual fue comparar el uso de heparina y 
enoxaparina solos y junto con medias de compresión en 
términos de incidencia de trombosis venosa profunda.
Metodología: Para realizar la investigación, 80 pacientes 
fueron asignados aleatoriamente a 4 grupos de hepari-
na sola, heparina junto con medias, enoxaparina sola y 
enoxaparina junto con medias (cada una contenía 20 pa-
cientes). En el primer grupo, se utilizó heparina a la dosis 
de 5000 unidades por 12 horas durante 3 días por vía 
subcutánea. En el segundo grupo, además de heparina, 
también se utilizaron medias de compresión. En el tercer 
grupo sometido a profilaxis, la enoxaparina a la dosis de 
40 mg por día durante tres días se usó por vía subcutánea. 
En el cuarto grupo, además de la enoxaparina, también se 
utilizaron medias de compresión. Dos semanas después 
de la finalización de la profilaxis médica y mecánica, se 
examinó la trombosis mediante ecografía Doppler. Los da-
tos se analizaron utilizando SPSS, versión 22, software y 
prueba de chi-cuadrado (prueba de Fisher) y ANOVA.
Resultados: Sólo se observaron dos casos de trombosis 
(un caso en el primer grupo y un caso en el tercer grupo). 
No se observó ningún caso de trombosis en los grupos 
que recibieron medias de compresión junto con el medi-
camento. La prueba exacta de Fisher indicó que no hubo 
diferencias significativas entre los cuatro grupos en cuanto 
a la incidencia de trombosis.
Conclusión: la adición de medias de compresión a hepa-
rina o enoxaparina no tuvo un efecto significativo en la 
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reducción de la incidencia de trombosis venosa profunda 
en pacientes con histerectomía.
Palabras clave: heparina, enoxaparina, medias, trombo-
sis venosa profunda, histerectomía. 
enous thromboembolism, including deep 
vein thrombosis and pulmonary embo-
lism, is a common complaint in ill pa-
tients1. Ill patients are prone to deep vein thrombosis due 
to factors such as surgery, catheter, immobility, or the use 
of sedative or crippling medicines. Clinical processes of 
this disease can be very risky2. For this reason, preventive 
measures such as the use of anticoagulants in patients 
prone to deep vein thrombosis are crucial3. Venous throm-
boembolism is the second most common cardiovascular 
disease following myocardial infarction4. The high preva-
lence of pulmonary embolism and its high mortality, espe-
cially when it is not diagnosed, indicates the need for pro-
per use of imaging techniques for evaluation of patients 
suspected of pulmonary embolism.
The standard diagnostic method for patients suspected 
of pulmonary embolism starts with perfusion ventilation 
scanning5. Almost half of the patients with pelvic vein 
thrombosis or proximal deep proximal vein thrombosis in 
lower limbs have pulmonary thrombosis, which is usually 
not symptomatic. In this regard, leg vein thrombosis lone 
has a lower risk for pulmonary embolism6.
Deep vein thrombosis is considered as an immediate 
threat to the patient’s life with a potential to become a 
pulmonary embolism. It also leads to long-term venous 
insufficiency in the lower limb veins7. These patients are 
mostly asymptomatic31. Patients undergoing neuromuscu-
lar surgery are more prone to venous thromboembolism30. 
The factors predisposing these people to thromboembo-
lism include long duration of surgery, the release of brain 
thromboplastic substances during surgery, the need for 
long rest after surgery and immobilization of the upper 
and lower limbs, the possibility of neurological injuries du-
ring surgery, the need for treatment with high doses of 
glucocorticoids in some patients, and the need for using 
osmotic and non-osmotic diuretics and dehydration8.
Deep vein thrombosis diagnosis in the legs is usually diffi-
cult, since only one of several leg veins might be involved 
and might cause no disturbance in the blood flow of legs9.
In this group of patients, D dimer, as a molecule resulting 
from fibrin breakdown, is a sensitive indicator, although 
its specialty is low. Venous duplex ultrasonography, as a 
non-invasive and simple method, is commonly used in 
this group of patients for diagnosis. The sensitivity of this 
diagnostic method is 75% in deep vein thrombosis and 
75% for symptomatic cases in leg10,11. Anticoagulants re-
duce the blood coagulation. These medicines are known 
as blood diluents and are used to stop the formation of 
clots in people who are at risk of formation of clots and 
preventing the growth of current clots12. These substances 
break down the clots which have not been present before 
(the body will dissolve the current clots over time)33. An-
ticoagulants can be used as pills (warfarin) or in injecting 
form (heparin) or (enoxaparin)13. In addition, the use of 
compression elastic stockings can reduce the chronic swe-
lling caused by the formation of clot in the leg, since swe-
lling of the leg is due to damage to the valves in the legs. 
The compression stockings cover the leg arch to the top or 
bottom of the knee. These stockings are tightly fastened 
to the wrists and loosened to the top of the legs, which 
causesa lot of pressure on the leg. This pressure prevents 
blood stasis and the formation of a clot14.
In a study conducted by Major in 2003 on 100 trauma pa-
tients hospitalized in ICU after surgery, it was found that 
patients received both mechanical and medical methods 
experienced less deep vein thrombosis compared to those 
who received only prophylaxis12. In the study conducted 
by Geerts et al., it was shown that in patients who used 
mechanical prophylaxis, ultrasound findings were found 
in the favor of thrombosis, while in patients who used 
medicine prophylaxis, no finding in favor of thrombosis 
was found13.
In a study conducted by Mohammad Zadeh Ghare Baghi 
et al., in Tabriz, 75 patients with traumatic spinal cord in-
jury were divided into three groups (each contained 25) 
and three methods of compression stockings along with 
enoxaparin and compression stockings along with hepa-
rin and compression stockings alone were compared to 
prevent deep vein thrombosis32. No significant differen-
ce was found in the method of prevention of thrombosis 
among the three groups in terms of adding medical pre-
vention methods of heparin and enoxaparin to mechani-
cal methods in these patients15.
Hysterectomy is one of the most commonly used surge-
ries. Following cesarean section, it is the second most 
common surgery in the United States16,17. In this country, 
about 40% of women have hysterectomy before the age 
of 6018. The likelihood of this surgery in women depends 
on a number of factors such as age, race, living place, 
gender, physician19. 
The most important indications for this surgery include 
leiomyoma, abnormal uterine bleeding, adenomyosis, en-
dometriosis, uterine prolapse, pelvic pain, and treatment-
resistant dysmenorrhea. This surgery is performed in se-
vere vaginal bleeding after labor. Cervical, uterine and 
ovarian malignancies and inflammatory diseases are some 
of the causes for this surgery17. In a study, 2704 patients 
were evaluated for the risk of thrombosis before the sur-
gery and it was found that 74 of them faced a risk for 
thrombosis. In the mentioned study, 70% of patients re-
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ceived heparin before and after surgery, and 28% recei-
ved only heparin after surgery. A total of 7 patients had 
thrombosis20. In another study, the incidence and conse-
quences of deep vein thrombosis in gynecological surgery 
were examined. The results showed that 53 patients had 
thrombosis or pulmonary embolism after 30 thousand 
surgeries (1 case per 500 surgeries). In the mentioned stu-
dy, 91% of patients received a type of prevention. The 
rate of embolism and thrombosis was very low in patients 
with benign disease, anesthesia less than 3 hours, and no 
history of embolism or thrombosis or v-factor reduction 
(one case per 4,000 surgeries)21.
Several studies have been conducted on the effects of 
different methods of medical and mechanical prevention 
of thrombosis in various surgeries and diseases such as 
trauma12, spinal cord injury15,22, hip joint replacement23, 
brain tumor patients under craniotomy24, stroke25, spinal 
surgery26 and even gynecological diseases27,28. In some ca-
ses, a significant difference between the use of different 
medical and mechanical methods alone or in combination 
with each other has been reported. In some cases, their 
effects have been reported equal. However, it seems that 
no study has yet been conducted to compare the effects 
of heparin and enoxaparin and compression stockings on 
prophylaxis of deep vein thrombosis in hysterectomy pa-
tients. Thus, conducting a study to compare heparin and 
enoxaparin and compression stockings in prophylaxis of 
deep vein thrombosis seems to be necessary in hysterec-
tomy patients, so that if the reduction in the incidence 
of thrombosis was seen in people using any prophylaxis, 
the same treatment could be used in patients to reduce 
thrombosis and its complications34. 
his study was an interventional study. The in-
clusion criteria of study included women requi-
red hysterectomy and aged less than 60 years. 
Patients referring to the radiology unit of Afzalipour Hos-
pital in Kerman during the years 2017-2018 who had un-
derwent hysterectomy were selected as the participants of 
the current study.
The research exclusion criteria included cases of hyste-
rectomy due to malignancy, patients with the history of 
taking aspirins, patients with a history of pelvic trauma, 
patients with a history of diabetes, patients with a history 
of heart failure and lung disease, patients with a history 
of previous thrombosis, patients with history of long-term 
hospitalization, and obese patients (20% ideal weight<). 
Convenient sampling was used in this study. The sample 
size was determined to be 80 people based on cases of 
hysterectomy surgery in women. Patients were randomly 
divided into four groups, including prophylaxis along with 
heparin, heparin along with compression stockings, pro-
phylaxis along with enoxaparin, and enoxaparin along 
with compression stockings. They were assigned ran-
domly into these groups using random numbers` table. In 
the first group, subcutaneous heparin at the dose of 5000 
units per 12 hours for 3 days was used. In the second 
group, in addition to heparin, compression stockings 
were utilized. In the third group underwent prophylaxis, 
subcutaneous enoxaparin at the dose of 40 mg per day 
for three days was used. In the fourth group, in addition 
to enoxaparin, compression stockings were also used.
The compression stockings used by patients were top 
of knee type and they were made in Iran. The medical 
treatment lasted up to three days after surgery. The use 
of stockings was also continued immediately after leaving 
the operating room up to two weeks at home. Two wee-
ks after the completion of the medical and mechanical 
prophylaxis, the patients underwent Doppler ultrasound 
by a radiologist who did not have information on pro-
phylaxis method. Doppler ultrasound findings were recor-
ded in the checklist (presence or absence of thrombosis). 
Data were analyzed using SPSS, version 22, software. 
Chi-square (Fisher’s test) and ANOVA tests were used to 
analyze the data and compare the groups. The significan-
ce level was considered less than 0.05.
All ethical considerations were observed in this research. 
All steps and research objectives were explained for them. 
Their unwillingness to participate in the study had no 
effect on the normal course of treatment, and patients 
were allowed to leave the study at any time. Moreover, 
no additional cost including ultrasound was imposed on 
the patients. The license was obtained from Ethics Com-
mittee of Kerman University of Medical Sciences before 
the study began and the necessary code was obtained for 
the clinical trial study.
he mean age of the patients was 50.16 ± 5.66. 
The minimum and maximum age was 40 and 
60 years, respectively. The mean age of the pa-
tients in four groups is presented in the table. As shown, 
there was no significant difference among the groups in 
terms of age.
Based on (Table 1), only two cases of thrombosis (one 
case in the groups used only heparin and one case in the 
group used only enoxaparin) and no case of thrombo-
sis was seen in the groups using compression stockings 
in addition to medicines. Fisher’s exact test showed that 
there was a significant difference between the use of he-
parin alone or heparin along with compression stockings 
(P=0.5), between heparin group and enoxaparin group 
(P=0.756), and between the group used enoxaparin alo-
ne and the group used enoxaparin along with stockings 
(P=0.5) in terms of incidence of thrombosis.
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Table 1.Comparison of mean age and thrombosis in the studied group
Groups studied
Heparin
Heparin and compression 
stockings
Enoxaparin
Enoxaparin and com-
pression stockings
P value
Age mean and SD 50.2 ±5.7 50.5 ±5.7 49.15±5.7 50.8 ±5.8 0.8160
thrombosis * positive (5) 1 - (5) 1 - >0.05
negative (95) 19  (100) 20 (95) 19 (100) 20
*Numbers are presented in number (percentage)
n this study, 80 patients in 4 groups were studied. 
In two groups, heparin and enoxaparin were used 
alone. In two other groups, in addition to these 
medicines, compression stockings were used. The results 
revealed that only two cases of deep vein thrombosis oc-
curred (2.5%). The mentioned two cases included 1 case 
in the heparin group and 1 case in the enoxaparin group. 
There was no case of thrombosis in the groups using these 
stockings. All research hypotheses were confirmed and it 
was found that there was no significant difference bet-
ween the four groups in terms of incidence of deep vein 
thrombosis. There are not many studies regarding the use 
of medical methods to prevent thrombosis along with me-
chanical methods in hysterectomy. Previous studies had 
mainly focused on the risk factors of thrombosis in gyne-
cological surgery or the effects of different types of me-
dical therapy in prevention of this complication. Studies 
have also been conducted on other surgical procedures.
In short, the results showed that deep vein thrombosis 
was very low in hysterectomy (2.5%). In a retrospective 
case-control study, the rate of complications of abdomi-
nal and vaginal hysterectomy during the years 2001 and 
2002 in Shahid Yahyanejad Hospital of Babol was repor-
ted as follows: 32.7% in abdominal group and 5.3% in 
the vaginal group. Rate of thrombosis was not reported in 
this study29.Another study showed that out of a total of 
2704 patients undergoing gynecological surgery, only 74 
had risk for thrombosis, and only 7 patients had throm-
bosis. The researchers concluded that the incidence of 
thrombosis in gynecological surgery was not high and had 
a close association with the risks of thrombosis20. Another 
study examined the incidence and consequences of deep 
vein thrombosis in gynecological surgery. It was found that 
53 patients had thrombosis or pulmonary embolism after 
30000 gynecological surgeries (one case per 500 surgeries).
In the mentioned study, 91% of patients received a type of 
prevention. The rate of thrombosis or embolism was signi-
ficantly lower in patients with benign disease, anesthesia 
less than 3 hours, and no history of embolism or throm-
bosis, or v-factor reduction (one case per 4,000 surgeries). 
The researchers concluded that the rate of embolism and 
thrombosis in women undergoing gynecological surgery 
was low21.
The present study revealed no significant difference bet-
ween two types of medicines (heparin and enoxaparin) 
in terms of incidence of deep vein thrombosis (1 case of 
thrombosis was observed in each group). Various studies 
have been conducted to compare the effects of various 
medicines.For example, a study compared the effects of 
heparin and enoxaparin in preventing deep vein thrombo-
sis after hip joint replacement surgery. The first group re-
ceived heparin at a the dose of 5,000 units per 8 hours for 
20 days, the second group received enoxaparin at the dose 
of 40 mg per day for 10 days, and the third group received 
enoxaparin at the dose of 40 mg per day for 20 days.
In this study, 31 patients (77.5%) in the first group, 23 pa-
tients (57.5%) in the second group, and 4 (10%) patients 
in the third group had symptoms of thrombosis during 
hospitalization. The difference between the first and se-
cond groups (p = 0.047), the difference between the first 
and third groups (p <0.001) and the difference between 
the second and third groups (p <0.001) were significant. 
Hence, enoxaparin at the dose of 40 mg per day for 20 
days was recognized more appropriate23. In another study, 
the effect of normal heparin and low molecular weight 
heparin (clexane) on the prevention of deep vein throm-
bosis in patients with brain tumor under craniotomy was 
compared. The first group received clexane at the dose 
of 40 mg subcutaneously and the second group received 
normal heparin at the dose of 5000 units per 12 hoursaf-
ter craniotomy surgery. The rate of deep vein thrombosis 
included 14 (18.2%) people in the normal heparin group 
and 3 (3.9%) people in the second group. This difference 
was significant. Generally, it was found that clexane was 
more appropriate than normal heparin24.
Some studies have also been conducted on gynecological 
surgery. For example, a study was conducted to compare 
low molecular weight heparin with the lack of receiving 
this medicine in gynecological surgery. In the non-treated 
group, 4 cases of pulmonary embolism (0.22%), two ca-
ses of fatal embolisms (0.11%), 13 cases of proximal deep 
vein thrombosis (72.0%) and 41 cases of distal deep vein 
thrombosis (2.3%) were seen. In the second group, no 
case of embolism was observed. Rather, 3 cases of proxi-
mal deep vein thrombosis (0.16%) and 18 cases of distal 
deep vein thrombosis (0.96%) were observed. Among 
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patients with vaginal hysterectomy, in the control and 
treatment groups, only 1 patient out of 41 (2.4%) pa-
tients and 2) patients out of 40 patients (5%), respectively, 
had deep vein thrombosis. 
In the control group undergoing abdominal hysterectomy, 
2 cases of pulmonary embolism (0.27%), 1 fatal embolism 
(0.13%), 9 cases of proximal deep vein thrombosis (1.2%) 
and 20 cases of distal deep vein thrombosis (2.7%) were 
observed. In patients undergoing abdominal hysterectomy 
and received heparin, 1 case of proximal deep vein throm-
bosis (0.13%) and 10 cases of distal deep vein thrombosis 
(1.4%) were observed. Thus, the use of heparin with low 
molecular weight was effective in preventing thrombosis 
in women undergoing surgery28. Another study was con-
ducted to compare the effect of low molecular weight 
heparin along with dihydroergotamine (LMWH-DHE) and 
conventional heparin-DHE along with Acenocoumarol 
(heparin-DHE / A) in 191 patients undergoing gynecolo-
gical surgery.
It was found that LMWH-DHE was not different from 
heparin-DHE/A in preventing thrombosis and the rate of 
bleeding and side effects. Only one case of thrombosis 
occurred in each group and only one case of non-fatal 
pulmonary embolism occurred in the LMWH-DHE group. 
The authors concluded that LMWH-DHE was an attracti-
ve, safe and effective method in preventing thromboem-
bolism in gynecological surgery27.
In general, above-mentioned studies suggested that me-
dical methods were effective in preventing thrombosis in 
surgery, and lower molecular weight heparin was more 
approproate than normal heparin in surgeries, including 
gynecological surgery. Although the rate of thrombosis 
was low in both groups in the present study (1 case out 
of 20 cases), no significant difference was seen between 
the two medical groups, which might be due to the small 
sample size of the study.
In the present study, no case of deep vein thrombosis 
was seen in the groups using the medicine along with 
compression stockings. However, the comparison of these 
two groups (heparin along with stockings and enoxaparin 
along with stockings) and their comparison with medicine 
alone showed that using stockings along with medicine 
did not significantly reduce the incidence of thrombosis. 
In this regard, no study was found in the area of hysterec-
tomy or gynecological surgery. In other surgeries, the use 
of medical and mechanical methods such as stockings has 
been compared. For example, a study was conducted to 
compare the effect of using compression stockings alo-
ne or along with low doses of heparin or enoxaparin in 
preventing deep vein thrombosis in patients with spinal 
cord injury. Compression stockings along with enoxaparin 
(40 mg/day) were subcutaneously used in the first group, 
compression stockings along with low doses of heparin 
(5000 units per 12 hours daily) were subcutaneously used 
in the second group, and only stockings were used in the 
third group. Based on the findings, a total of 5 patients 
(6.7%) had deep vein thrombosis (3 patients in the first 
group and 1 patient in each of other groups). No signi-
ficant difference was observed among three groups 15. 
In another study, the effect of compression stockings and 
heparin on the prevention of deep vein thrombosis in 
stroke patients was compared.
In the first group, heparin at a dose of 5000 units per 12 
hours was subcutaneously used, and in the second group, 
compressions stockings were used during the hospitali-
zation. In general, 5 patients (5%) had thrombosis du-
ring the study, which 2 (4%) of them were in the heparin 
group and 3 (6%) were in the stockings group. As a result, 
no significant difference was seen in terms of the inciden-
ce of thrombosis25. A study was conducted in India in 
2009 on patients with spinal cord injuries. In this study, 
279 patients receiving physiotherapy were studied in two 
groups of heparin and mechanical prevention (physical 
therapy alone). Based on the results, the rate of thrombo-
sis was 1.8% in the heparin group and it was 3% in the 
second group. Thus, the use of heparin with a preventati-
ve dose had no effect on reducing thrombosis. Moreover, 
the use of mechanical methods was effective in reducing 
deep vein thrombosis22. These studies suggested that 
although the use of mechanical methods was effective, 
adding them to medical method, did not necessarily pro-
duce a significant difference in the reduction of deep vein 
thrombosis. These results were in line with those of the 
present study.
n summary, this study revealed no significant diffe-
rence between heparin and enoxaparin alone or in 
combination with compression stockings in terms of 
incidence of deep vein thrombosis. Based on the research 
results, the following recommendations are presented: 
1- Replication of the current research in other centers and 
conducting similar research on other gynecological sur-
geries.
2- The current research did not reveal a significant diffe-
rence among different groups in terms of incidence of 
deep vein thrombosis, which might be due to a small 
sample size. Therefore, it is recommended that the cu-
rrent research can be replicated with a larger sample size.
3- It is recommended that in addition to deep vein throm-
bosis, other complications such as the duration of hos-
pitalization and pulmonary embolism can be conside-
red in future studies.
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